世界の呼吸補助装置市場:医療機器パイプライン分析2016

◆英語タイトル:Respiratory Assist Devices - Medical Devices Pipeline Assessment, 2016
◆商品コード:GDME0205EPD
◆発行会社(調査会社):GlobalData
◆発行日:2016年6月6日
◆ページ数:76
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥285,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥570,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD7,500 ⇒換算¥855,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、呼吸補助装置のグローバル製品パイプライン動向について調査・分析し、以下の構成でお届けいたします。
・呼吸補助装置の概要
・呼吸補助装置の開発動向:開発段階別分析
・呼吸補助装置の開発動向:セグメント別分析
・呼吸補助装置の開発動向:領域別分析
・呼吸補助装置の開発動向:規制Path別分析
・呼吸補助装置の開発動向:承認日(推定)別分析
・企業別呼吸補助装置の開発動向(パイプライン製品、進行中の治験)
・呼吸補助装置の最近動向
【レポートの概要】

Respiratory Assist Devices – Medical Devices Pipeline Assessment, 2016

Summary

GlobalData’s Medical Devices sector report, “Respiratory Assist Devices – Medical Devices Pipeline Assessment, 2016″ provides an overview of Respiratory Assist Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Respiratory Assist Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Respiratory Assist Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Respiratory Assist Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Respiratory Assist Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 6
2 Introduction 7
2.1 Respiratory Assist Devices Overview 7
3 Products under Development 8
3.1 Respiratory Assist Devices – Pipeline Products by Stage of Development 8
3.2 Respiratory Assist Devices – Pipeline Products by Segment 9
3.3 Respiratory Assist Devices – Pipeline Products by Territory 10
3.4 Respiratory Assist Devices – Pipeline Products by Regulatory Path 11
3.5 Respiratory Assist Devices – Pipeline Products by Estimated Approval Date 12
3.6 Respiratory Assist Devices – Ongoing Clinical Trials 13
4 Respiratory Assist Devices – Pipeline Products under Development by Companies 14
4.1 Respiratory Assist Devices Companies – Pipeline Products by Stage of Development 14
4.2 Respiratory Assist Devices – Pipeline Products by Stage of Development 15
5 Respiratory Assist Devices Companies and Product Overview 16
5.1 ALung Technologies, Inc. Company Overview 16
5.1.1 ALung Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 16
5.2 Breethe, Inc. Company Overview 22
5.2.1 Breethe, Inc. Pipeline Products & Ongoing Clinical Trials Overview 22
5.3 Case Western Reserve University Company Overview 23
5.3.1 Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview 23
5.4 Haemair Limited Company Overview 24
5.4.1 Haemair Limited Pipeline Products & Ongoing Clinical Trials Overview 24
5.5 Liberate Medical, LLC Company Overview 25
5.5.1 Liberate Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 25
5.6 McGowan Institute for Regenerative Medicine Company Overview 29
5.6.1 McGowan Institute for Regenerative Medicine Pipeline Products & Ongoing Clinical Trials Overview 29
5.7 MedArray Inc. Company Overview 31
5.7.1 MedArray Inc. Pipeline Products & Ongoing Clinical Trials Overview 31
5.8 Michigan Critical Care Consultants, Inc. Company Overview 32
5.8.1 Michigan Critical Care Consultants, Inc. Pipeline Products & Ongoing Clinical Trials Overview 32
5.9 Miromatrix Medical Inc. Company Overview 33
5.9.1 Miromatrix Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 33
5.10 Pneumedicare Ltd. Company Overview 34
5.10.1 Pneumedicare Ltd. Pipeline Products & Ongoing Clinical Trials Overview 34
5.11 Rice University Company Overview 35
5.11.1 Rice University Pipeline Products & Ongoing Clinical Trials Overview 35
5.12 The Charles Stark Draper Laboratory Inc Company Overview 36
5.12.1 The Charles Stark Draper Laboratory Inc Pipeline Products & Ongoing Clinical Trials Overview 36
5.13 University of California, Los Angeles Company Overview 38
5.13.1 University of California, Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 38
5.14 University of California, San Francisco Company Overview 39
5.14.1 University of California, San Francisco Pipeline Products & Ongoing Clinical Trials Overview 39
5.15 University of Kansas Company Overview 41
5.15.1 University of Kansas Pipeline Products & Ongoing Clinical Trials Overview 41
5.16 University of Pittsburgh Company Overview 43
5.16.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 43
5.17 Vivonics, Inc. Company Overview 45
5.17.1 Vivonics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 45
5.18 Xenios AG Company Overview 46
5.18.1 Xenios AG Pipeline Products & Ongoing Clinical Trials Overview 46
6 Respiratory Assist Devices- Recent Developments 48
6.1 Jun 01, 2016: MGC Diagnostics Reports Fiscal 2016 Second Quarter Results 48
6.2 May 11, 2016: Teleflex Raises USD400 Million in Public Offering of 4.875% Notes Due 2026 49
6.3 May 10, 2016: Capnia Reports First Quarter 2016 Financial Results 49
6.4 May 09, 2016: Inogen Announces First Quarter 2016 Financial Results 51
6.5 Apr 28, 2016: Teleflex Reports First Quarter 2016 Results 53
6.6 Mar 14, 2016: Inogen Announces Fourth Quarter and Full Year 2015 Financial Results and Updates 2016 Guidance 54
6.7 Feb 25, 2016: Teleflex Reports Fourth Quarter and Full Year 2015 Results; Provides 2016 Guidance 57
6.8 Feb 22, 2016: ALung Technologies Raises USD12 Million in Financing Round 59
6.9 Feb 15, 2016: New study shows promise of ALung’s Hemolung technology to help protect the injured lung 59
6.10 Jan 19, 2016: Leading Medical Device Companies Select Brainshark to Drive Sales Productivity 60
6.11 Dec 22, 2015: XENiOS Will Seek Regulatory Approval for i-lung 60
6.12 Dec 02, 2015: ALung’s Artificial Lung Technology Selected for Use in Landmark Respiratory Failure Trial 61
6.13 Nov 30, 2015: Inogen Provides Additional Full Year 2016 Guidance 62
6.14 Nov 30, 2015: Teleflex to focus on showcasing its Intraosseous and Central Vascular Access portfolio featuring chlorhexidine based technologies at GAVeCeLT 2015 – December 1-3, in Milan, Italy 62
6.15 Nov 10, 2015: Inogen Announces Third Quarter 2015 Financial Results 63
6.16 Nov 04, 2015: ALung Technologies Receives Expedited Access Pathway Designation from FDA for Hemolung Respiratory Assist System 64
6.17 Oct 29, 2015: Teleflex Reports Third Quarter 2015 Results 65
6.18 Sep 15, 2015: Teleflex Focuses on Innovative Technologies for the Emergency Airway at EMS World Expo 2015 66
6.19 Aug 17, 2015: Teleflex Signs New Agreement with Amerinet for Surgical Instruments 67
6.20 Aug 11, 2015: Inogen Announces Second Quarter 2015 Financial Results 67
6.21 Aug 03, 2015: New Publications Show Promise of Improved Artificial Lung Devices 69
6.22 Jul 30, 2015: Teleflex Reports Second Quarter 2015 Results 69
6.23 Jun 18, 2015: ALung Technologies Receives CE Mark for New Hemolung XG4 Cartridge Kit 71
6.24 Jun 18, 2015: ALung Technologies Receives CE Mark for New Hemolung XG4 Catheter Kit 71
7 Appendix 73
7.1 Methodology 73
7.2 About GlobalData 75
7.3 Contact Us 76
7.4 Disclaimer 76

1.1 List of Tables
Table 1: Respiratory Assist Devices - Pipeline Products by Stage of Development 8
Table 2: Respiratory Assist Devices - Pipeline Products by Segment 9
Table 3: Respiratory Assist Devices - Pipeline Products by Territory 10
Table 4: Respiratory Assist Devices - Pipeline Products by Regulatory Path 11
Table 5: Respiratory Assist Devices - Pipeline Products by Estimated Approval Date 12
Table 6: Respiratory Assist Devices - Ongoing Clinical Trials 13
Table 7: Respiratory Assist Devices Companies - Pipeline Products by Stage of Development 14
Table 8: Respiratory Assist Devices - Pipeline Products by Stage of Development 15
Table 9: ALung Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 16
Table 10: Hattler Catheter - Product Status 16
Table 11: Hattler Catheter - Product Description 17
Table 12: Hemolung Respiratory Assist System - Product Status 17
Table 13: Hemolung Respiratory Assist System - Product Description 18
Table 14: ALung Technologies, Inc. - Ongoing Clinical Trials Overview 19
Table 15: Hemolung Respiratory Assist System - Extra-corporeal CO2 Removal as an Adjunct to Non-Invasive Ventilation in Acute Severe Exacerbations of COPD 20
Table 16: Hemolung Respiratory Assist System - Physiological Study of Minimally Invasive Extracorporeal CO2 Removal in Exacerbations of COPD Requiring Invasive Mechanical Ventilation 20
Table 17: Hemolung Respiratory Assist System - Protective Ventilation with Veno-venous Lung Assist in Respiratory Failure 21
Table 18: Breethe, Inc. Pipeline Products & Ongoing Clinical Trials Overview 22
Table 19: OXY-1 - Product Status 22
Table 20: OXY-1 - Product Description 22
Table 21: Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview 23
Table 22: Case Western Portable Artificial Lung - Product Status 23
Table 23: Case Western Portable Artificial Lung - Product Description 23
Table 24: Haemair Limited Pipeline Products & Ongoing Clinical Trials Overview 24
Table 25: Blood/Air Mass Exchanger - Product Status 24
Table 26: Blood/Air Mass Exchanger - Product Description 24
Table 27: Liberate Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 25
Table 28: Non-invasive Electrical Stimulator - Product Status 25
Table 29: Non-invasive Electrical Stimulator - Product Description 25
Table 30: VentFree - Product Status 26
Table 31: VentFree - Product Description 26
Table 32: Liberate Medical, LLC - Ongoing Clinical Trials Overview 27
Table 33: VentFree - VentFree: A Novel Abdominal Stimulator to Assist With Ventilator Weaning 28
Table 34: McGowan Institute for Regenerative Medicine Pipeline Products & Ongoing Clinical Trials Overview 29
Table 35: Biohybrid Artificial Lung - Product Status 29
Table 36: Biohybrid Artificial Lung - Product Description 30
Table 37: Chronic Artificial Lung - Product Status 30
Table 38: Chronic Artificial Lung - Product Description 30
Table 39: MedArray Inc. Pipeline Products & Ongoing Clinical Trials Overview 31
Table 40: Artificial Lung Fiber - Product Status 31
Table 41: Artificial Lung Fiber - Product Description 31
Table 42: Michigan Critical Care Consultants, Inc. Pipeline Products & Ongoing Clinical Trials Overview 32
Table 43: BioLung - Product Status 32
Table 44: BioLung - Product Description 32
Table 45: Miromatrix Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 33
Table 46: Miromatrix Artificial Lung - Product Status 33
Table 47: Miromatrix Artificial Lung - Product Description 33
Table 48: Pneumedicare Ltd. Pipeline Products & Ongoing Clinical Trials Overview 34
Table 49: Pneumonitor - Product Status 34
Table 50: Pneumonitor - Product Description 34
Table 51: Rice University Pipeline Products & Ongoing Clinical Trials Overview 35
Table 52: Respiratory Assist Device - Product Status 35
Table 53: Respiratory Assist Device - Product Description 35
Table 54: The Charles Stark Draper Laboratory Inc Pipeline Products & Ongoing Clinical Trials Overview 36
Table 55: Silicone-Based Microfluidic Artificial Lung - Product Status 36
Table 56: Silicone-Based Microfluidic Artificial Lung - Product Description 37
Table 57: University of California, Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 38
Table 58: Percutaneous Catheter for Lung Assist Device - Product Status 38
Table 59: Percutaneous Catheter for Lung Assist Device - Product Description 38
Table 60: University of California, San Francisco Pipeline Products & Ongoing Clinical Trials Overview 39
Table 61: Gas Exchange Membrane - Product Status 39
Table 62: Gas Exchange Membrane - Product Description 39
Table 63: Neonatal ECMO Device - Product Status 40
Table 64: Neonatal ECMO Device - Product Description 40
Table 65: University of Kansas Pipeline Products & Ongoing Clinical Trials Overview 41
Table 66: VestibuGLIDE System - Product Status 41
Table 67: VestibuGLIDE System - Product Description 42
Table 68: University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 43
Table 69: Paracorporeal Ambulatory Assist Lung - Product Status 43
Table 70: Paracorporeal Ambulatory Assist Lung - Product Description 44
Table 71: Vivonics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 45
Table 72: Implantable Artificial Lung - Product Status 45
Table 73: Implantable Artificial Lung - Product Description 45
Table 74: Xenios AG Pipeline Products & Ongoing Clinical Trials Overview 46
Table 75: i-lung - Product Status 46
Table 76: i-lung - Product Description 46
Table 77: Xtralung - Product Status 47
Table 78: Xtralung - Product Description 47
Table 79: Glossary 74

1.2 List of Figures
Figure 1: Respiratory Assist Devices - Pipeline Products by Stage of Development 8
Figure 2: Respiratory Assist Devices - Pipeline Products by Segment 9
Figure 3: Respiratory Assist Devices - Pipeline Products by Territory 10
Figure 4: Respiratory Assist Devices - Pipeline Products by Regulatory Path 11
Figure 5: Respiratory Assist Devices - Pipeline Products by Estimated Approval Date 12
Figure 6: Respiratory Assist Devices - Ongoing Clinical Trials 13

【掲載企業】

ALung Technologies, Inc.
Breethe, Inc.
Case Western Reserve University
Haemair Limited
Liberate Medical, LLC
McGowan Institute for Regenerative Medicine
MedArray Inc.
Michigan Critical Care Consultants, Inc.
Miromatrix Medical Inc.
Pneumedicare Ltd.
Rice University
The Charles Stark Draper Laboratory Inc
University of California, Los Angeles
University of California, San Francisco
University of Kansas
University of Pittsburgh
Vivonics, Inc.
Xenios AG

★調査レポート[世界の呼吸補助装置市場:医療機器パイプライン分析2016]販売に関する免責事項
★調査レポート[世界の呼吸補助装置市場:医療機器パイプライン分析2016]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆